Neurofibromatosis Research Program

Award Info:

Clinical Trial Award - The proposed clinical trial is expected to begin no later than 12 months after the award date, or 18 months after the award date for FDA-regulated studie


The vision of the FY20 NFRP is to decrease the clinical impact of NF. Toward this end, the
NFRP seeks to support innovative, high-impact research that will foster new directions for and
address neglected issues in NF research; sponsor multidisciplinary and multi-institutional
collaborations that will bring new perspectives to the field; promote translational and clinical
studies to move promising ideas from bench to bedside; and develop a balanced portfolio of
meritorious research related to all aspects of NF1, NF2, and schwannomatosis